Prime Medicine Inks Cell Therapy Pact With Bristol Myers Squibb Worth Over $3.5B, Streamlines Pipeline
On Monday, Prime Medicine Inc. (NASDAQ:PRME) announced a strategic research collaboration and license agreement with Bristol ...
Prime Medicine Shares Rally on Partnership With Bristol Myers Squibb
Prime Medicine said it will receive a $55 million upfront payment and a $55 million investment from Bristol Myers Squibb. It will is also eligible to receive more than $3.5 billion in milestones, ...
Alexandria Real Estate Equities, Inc. Named One of the World's Most Trustworthy Companies by Newsweek
Alexandria Real Estate Equities, Inc. (NYSE: ARE), the first, preeminent, longest-tenured and pioneering owner, operator and ...
Le Lézard2m
Be Biopharma Announces Preclinical Data for Novel Engineered B Cell Medicine for the Potential Treatment of Hypophosphatasia
Be Biopharma, Inc. ("Be Bio"), a company pioneering the discovery and development of engineered B Cell Medicines (BCMs), today announced the presentation of preclinical data demonstrating the ...
Catch The Wave: Brazilian Sensation Marco Rio Signs With WORLD IPI To Launch Exciting New Line For Nicolas Of Palm Beach
Marco Rio, Singer/Songwriter/Surfer/Designer Marco embodies the quintessential spirit of youth and creativity that we aim to ...
MT Newswires on MSN21m
Traders Consolidate Positions in Final Session for Q3, Driving Cautious Losses for US Equity Futures
US equity futures posted narrow losses ahead of Monday's opening bell as Wall Street is set to kick off the final trading session of September. The Dow Jones Industrial Average futures fell 0.1%, S&P ...
AT&T offloads remaining stake in DirecTV to TPG in a $7.6 billion deal; shares up
AT&T Inc (NYSE:T) announced Monday that it plans to sell its 70% ownership in satellite TV provider DirecTV to private equity firm TPG for $7.6 billion, marking the telecom giant's exit from a ...